Providing patient information leaflets following COVID-19 treatment

Following treatment for COVID-19 with tocilizumab, sarilumab, or steroids, clinicians should provide suitable patient information leaflets at discharge. These are available for download from SPS website and completed by discharging clinicians before being handed to patients.

Specialist Pharmacy Service